While molecular profiling of localized PCa tumors with pathogenic BRCA2 variants has shown an increased genomic instability and a mutational profile similar to metastatic disease [6], the impact of other PGVs on PCa is less well understood. The gene discussed is BRCA2; the disease is posterior cortical atrophy.